Get the Stockscreener App
2.14
0.93%
-0.02
After Hours:
2.19
0.05
+2.34%
Inmed Pharmaceuticals Inc stock is traded at $2.14, with a volume of 89,896.
It is down -0.93% in the last 24 hours and down -3.17% over the past month.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
See More
Previous Close:
$2.16
Open:
$2.16
24h Volume:
89,896
Relative Volume:
0.05
Market Cap:
$4.28M
Revenue:
$4.96M
Net Income/Loss:
$-6.82M
P/E Ratio:
-0.0327
EPS:
-65.4
Net Cash Flow:
$-6.64M
1W Performance:
+1.42%
1M Performance:
-3.17%
6M Performance:
-19.85%
1Y Performance:
-61.87%
1-Day Range:
$2.11
$2.2799
1-Week Range:
$2.07
$2.2799
52-Week Range:
$1.72
$8.27
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
Name
Inmed Pharmaceuticals Inc
Sector
Phone
(604) 669-7207
Address
1445-885 WEST GEORGIA ST., VANCOUVER
Compare INM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INM
Inmed Pharmaceuticals Inc
|
2.14 | 4.34M | 4.96M | -6.82M | -6.64M | -65.40 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Inmed Pharmaceuticals Inc Stock (INM) Latest News
Multi asset correlation models including InMed Pharmaceuticals Inc.Market Risk Summary & Verified Swing Trading Watchlist - Newser
Is InMed Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Drop Watch & Accurate Buy Signal Alerts - Newser
Risk adjusted return profile for InMed Pharmaceuticals Inc. analyzedJuly 2025 Highlights & Verified Entry Point Signals - Newser
Can momentum traders help lift InMed Pharmaceuticals Inc.2025 Trading Recap & Reliable Volume Spike Trade Alerts - Newser
Visual analytics tools that track InMed Pharmaceuticals Inc. performanceJuly 2025 Trends & Weekly Setup with ROI Potential - Newser
Using Python tools to backtest InMed Pharmaceuticals Inc. strategies2025 Historical Comparison & Weekly Watchlist for Hot Stocks - Newser
Intraday pattern recognizer results for InMed Pharmaceuticals Inc.Trade Risk Report & Fast Entry High Yield Stock Tips - Newser
What data driven models say about InMed Pharmaceuticals Inc.’s futureJuly 2025 Momentum & Free Fast Entry Momentum Trade Alerts - Newser
Can trapped investors hope for a rebound in InMed Pharmaceuticals Inc.2025 AllTime Highs & Low Risk Growth Stock Ideas - Newser
Real time social sentiment graph for InMed Pharmaceuticals Inc.2025 Short Interest & Growth Focused Entry Point Reports - Newser
Will InMed Pharmaceuticals Inc. stock maintain dividend yieldJuly 2025 Reactions & Stock Market Timing Techniques - baoquankhu1.vn
Is InMed Pharmaceuticals Inc. building a consolidation baseWall Street Watch & Long-Term Capital Growth Strategies - Newser
Signal strength of InMed Pharmaceuticals Inc. stock in tech scannersWeekly Stock Recap & High Return Stock Watch Alerts - Newser
Backtesting results for InMed Pharmaceuticals Inc. trading strategiesJuly 2025 Short Interest & Expert Curated Trade Setup Alerts - Newser
Understanding InMed Pharmaceuticals Inc.’s price movementEarnings Overview Summary & Free High Accuracy Swing Entry Alerts - Newser
Can machine learning forecast InMed Pharmaceuticals Inc. recoveryPortfolio Risk Summary & Real-Time Market Sentiment Reports - Newser
How to forecast InMed Pharmaceuticals Inc. trends using time seriesProfit Target & Risk Managed Investment Strategies - Newser
Should you hold or exit InMed Pharmaceuticals Inc. nowJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser
Automated trading signals detected on InMed Pharmaceuticals Inc.CPI Data & Long-Term Growth Plans - Newser
Identifying reversal signals in InMed Pharmaceuticals Inc.July 2025 Earnings & Reliable Momentum Entry Alerts - Newser
Published on: 2025-09-10 01:24:07 - Newser
Trend analysis for InMed Pharmaceuticals Inc. this weekQuarterly Portfolio Review & Weekly High Potential Alerts - Newser
Institutional scanner results for InMed Pharmaceuticals Inc.July 2025 Short Interest & AI Driven Stock Reports - Newser
News impact scoring models applied to InMed Pharmaceuticals Inc.Weekly Trend Recap & Stock Portfolio Risk Control - Newser
Real time social sentiment graph for InMed Pharmaceuticals IncMarket Activity Summary & Low Risk High Win Rate Stock Picks - Newser
What to do if you’re stuck in InMed Pharmaceuticals Inc.2025 Top Decliners & Step-by-Step Swing Trade Plans - Newser
InMed Pharmaceuticals Inc. stock retracement – recovery analysisJuly 2025 Fed Impact & Low Drawdown Investment Ideas - Newser
Inmed Pharmaceuticals Inc Stock (INM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):